IL6 and neoplasm: In particular, IFIT3 enhances NF-κB activity, which subsequently promotes the secretion of inflammatory mediators such as IL-6, TNF-α, and COX-2, driving tumor cell proliferation, resistance to apoptosis, and angiogenesis (50, 51).